1. Home
  2. TARA vs REA Comparison

TARA vs REA Comparison

Compare TARA & REA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$3.92

Market Cap

236.1M

Sector

Health Care

ML Signal

HOLD

Logo Rare Earths Americas Inc. Common Stock

REA

Rare Earths Americas Inc. Common Stock

N/A

Current Price

$9.94

Market Cap

232.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
TARA
REA
Founded
N/A
N/A
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
236.1M
232.3M
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
TARA
REA
Price
$3.92
$9.94
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$24.40
N/A
AVG Volume (30 Days)
481.8K
124.2K
Earning Date
05-01-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
38.25
N/A
EPS
N/A
N/A
Revenue
$2,948,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.97
$8.95
52 Week High
$7.82
$17.84

Technical Indicators

Market Signals
Indicator
TARA
REA
Relative Strength Index (RSI) 41.88 32.57
Support Level $3.69 N/A
Resistance Level $4.23 $12.20
Average True Range (ATR) 0.17 0.96
MACD -0.01 -0.04
Stochastic Oscillator 19.09 25.36

Price Performance

Historical Comparison
TARA
REA

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

About REA Rare Earths Americas Inc. Common Stock

Rare Earths Americas Inc is an exploration stage company focused on advancing projects related to rare earth minerals. Its activities include evaluating mineralization and assessing the characteristics and economic potential of its assets. Its portfolio includes the Shiloh Project in Georgia, United States; the Alpha Project in Bahia, Brazil; and the Constellation Project in Minas Gerais, Brazil. It also holds additional early-stage exploration projects, including the Homer Project in Goiás, Brazil, and the Liberty Peak Project in Georgia, United States. The company has two reportable segments due to their geographical location: United States Mining Operations and Brazil Mining Operations.

Share on Social Networks: